Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 468

1.

Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4.

Guymer RH, Rosenfeld PJ, Curcio CA, Holz FG, Staurenghi G, Freund KB, Schmitz-Valckenberg S, Sparrow J, Spaide RF, Tufail A, Chakravarthy U, Jaffe GJ, Csaky K, Sarraf D, Monés JM, Tadayoni R, Grunwald J, Bottoni F, Liakopoulos S, Pauleikhoff D, Pagliarini S, Chew EY, Viola F, Fleckenstein M, Blodi BA, Lim TH, Chong V, Lutty J, Bird AC, Sadda SR.

Ophthalmology. 2019 Sep 30. pii: S0161-6420(19)32102-5. doi: 10.1016/j.ophtha.2019.09.035. [Epub ahead of print]

PMID:
31708275
2.

Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.

Pauleikhoff D, Bonelli R, Dubis AM, Gunnemann F, Rothaus K, Charbel Issa P, Heeren TF, Peto T, Clemons TE, Chew EY, Bird AC, Sallo FB; MacTel Study Group.

Acta Ophthalmol. 2019 Nov;97(7):e998-e1005. doi: 10.1111/aos.14110. Epub 2019 Apr 9.

PMID:
30968592
3.

Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study.

Csincsik L, MacGillivray TJ, Flynn E, Pellegrini E, Papanastasiou G, Barzegar-Befroei N, Csutak A, Bird AC, Ritchie CW, Peto T, Lengyel I.

Ophthalmic Res. 2018;59(4):182-192. doi: 10.1159/000487053. Epub 2018 Apr 5.

4.

Multimodal imaging of posterior ocular involvement in McArdle's disease.

Casalino G, Chan W, McAvoy C, Coppola M, Bandello F, Bird AC, Chakravarthy U.

Clin Exp Optom. 2018 May;101(3):412-415. doi: 10.1111/cxo.12635. Epub 2017 Nov 26. No abstract available.

PMID:
29178179
5.

Why the macula?

Bird AC, Bok D.

Eye (Lond). 2018 May;32(5):858-862. doi: 10.1038/eye.2017.247. Epub 2017 Nov 17. Review.

6.

Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT: Classification of Atrophy Report 3.

Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng CB, Jaffe GJ, Liakopoulos S, Monés JM, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Staurenghi G.

Ophthalmology. 2018 Apr;125(4):537-548. doi: 10.1016/j.ophtha.2017.09.028. Epub 2017 Nov 2. Erratum in: Ophthalmology. 2019 Jan;126(1):177.

PMID:
29103793
7.

CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Leung I, Sallo FB, Bonelli R, Clemons TE, Pauleikhoff D, Chew EY, Bird AC, Peto T; MacTel Study Group.

Retina. 2018 Jan;38 Suppl 1:S43-S50. doi: 10.1097/IAE.0000000000001842.

8.

Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.

Wolf-Schnurrbusch UEK, Leung I, Sallo FB, Clemons TE, Chew EY, Bird AC, Peto T; MacTel Study Group.

Ophthalmic Res. 2018;60(1):38-42. doi: 10.1159/000479932. Epub 2017 Sep 13.

9.

ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Sallo FB, Leung I, Zeimer M, Clemons TE, Dubis AM, Fruttiger M, Pauleikhoff D, Chew EY, Egan C, Peto T, Bird AC; MacTel Study Group.

Retina. 2018 Jan;38 Suppl 1:S79-S88. doi: 10.1097/IAE.0000000000001728.

10.

CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Sallo FB, Leung I, Clemons TE, Peto T, Chew EY, Pauleikhoff D, Bird AC; MacTel CNTF Research Group.

Retina. 2018 Jan;38 Suppl 1:S27-S32. doi: 10.1097/IAE.0000000000001706.

11.

LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.

Heeren TFC, Kitka D, Florea D, Clemons TE, Chew EY, Bird AC, Pauleikhoff D, Charbel Issa P, Holz FG, Peto T.

Retina. 2018 Jan;38 Suppl 1:S20-S26. doi: 10.1097/IAE.0000000000001715.

PMID:
28541959
12.

CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.

Peto T, Heeren TFC, Clemons TE, Sallo FB, Leung I, Chew EY, Bird AC.

Retina. 2018 Jan;38 Suppl 1:S8-S13. doi: 10.1097/IAE.0000000000001697.

PMID:
28505012
13.

Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration: Recommendations from Classification of Atrophy Consensus Meetings.

Holz FG, Sadda SR, Staurenghi G, Lindner M, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Curcio CA, Danis R, Fleckenstein M, Freund KB, Grunwald J, Guymer R, Hoyng CB, Jaffe GJ, Liakopoulos S, Monés JM, Oishi A, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Schmitz-Valckenberg S; CAM group.

Ophthalmology. 2017 Apr;124(4):464-478. doi: 10.1016/j.ophtha.2016.12.002. Epub 2017 Jan 18.

PMID:
28109563
14.

Progression of Vision Loss in Macular Telangiectasia Type 2.

Heeren TF, Clemons T, Scholl HP, Bird AC, Holz FG, Charbel Issa P.

Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3905-12. doi: 10.1167/iovs.15-16915.

PMID:
26070062
15.

Macular Telangiectasia Type 2 Without Clinically Detectable Vasculopathy.

Gillies MC, Mehta H, Bird AC.

JAMA Ophthalmol. 2015 Aug;133(8):951-4. doi: 10.1001/jamaophthalmol.2015.1796.

PMID:
26067680
16.

A Population-Based Ultra-Widefield Digital Image Grading Study for Age-Related Macular Degeneration-Like Lesions at the Peripheral Retina.

Lengyel I, Csutak A, Florea D, Leung I, Bird AC, Jonasson F, Peto T.

Ophthalmology. 2015 Jul;122(7):1340-7. doi: 10.1016/j.ophtha.2015.03.005. Epub 2015 Apr 11.

17.

Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye.

Thompson RB, Reffatto V, Bundy JG, Kortvely E, Flinn JM, Lanzirotti A, Jones EA, McPhail DS, Fearn S, Boldt K, Ueffing M, Ratu SG, Pauleikhoff L, Bird AC, Lengyel I.

Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1565-70. doi: 10.1073/pnas.1413347112. Epub 2015 Jan 20. Erratum in: Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3971.

18.

Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.

Chew EY, Clemons TE, Peto T, Sallo FB, Ingerman A, Tao W, Singerman L, Schwartz SD, Peachey NS, Bird AC; MacTel-CNTF Research Group.

Am J Ophthalmol. 2015 Apr;159(4):659-666.e1. doi: 10.1016/j.ajo.2014.12.013. Epub 2014 Dec 19.

19.

Multimodal imaging in type 2 idiopathic macular telangiectasia.

Sallo FB, Leung I, Clemons TE, Peto T, Bird AC, Pauleikhoff D.

Retina. 2015 Apr;35(4):742-9. doi: 10.1097/IAE.0000000000000365.

PMID:
25412037
20.

Biomarkers for disease progression and AAV therapeutic efficacy in feline Sandhoff disease.

Bradbury AM, Gray-Edwards HL, Shirley JL, McCurdy VJ, Colaco AN, Randle AN, Christopherson PW, Bird AC, Johnson AK, Wilson DU, Hudson JA, De Pompa NL, Sorjonen DC, Brunson BL, Jeyakumar M, Platt FM, Baker HJ, Cox NR, Sena-Esteves M, Martin DR.

Exp Neurol. 2015 Jan;263:102-12. doi: 10.1016/j.expneurol.2014.09.020. Epub 2014 Oct 5.

21.

Associations between autofluorescence abnormalities and visual acuity in idiopathic macular telangiectasia type 2: MacTel project report number 5.

Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T.

Retina. 2014 Aug;34(8):1630-6. doi: 10.1097/IAE.0000000000000110.

PMID:
24743635
22.

Geographic atrophy: a histopathological assessment.

Bird AC, Phillips RL, Hageman GS.

JAMA Ophthalmol. 2014 Mar;132(3):338-45. doi: 10.1001/jamaophthalmol.2013.5799.

23.

Agreement between time-domain and spectral-domain optical coherence tomography in the assessment of macular thickness in patients with idiopathic macular telangiectasia type 2.

Mathew R, Sivaprasad S, Florea D, Leung I, Sallo F, Clemons T, Bird AC, Peto T.

Ophthalmologica. 2013;230(3):144-50. doi: 10.1159/000353455. Epub 2013 Aug 24.

PMID:
23989133
24.

Is indocyanine green angiography useful for the diagnosis of macular telangiectasia type 2?

Niskopoulou M, Balaskas K, Leung I, Sallo FB, Clemons TE, Bird AC, Peto T; MacTel Study group.

Br J Ophthalmol. 2013 Jul;97(7):946-8. doi: 10.1136/bjophthalmol-2013-303118. Epub 2013 Mar 26. No abstract available.

PMID:
23532616
25.

Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3.

Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Wang JJ, Mitchell P, Ramdas WD, Vingerling JR; Macular Telangiectasia Project Research Group.

Ophthalmic Epidemiol. 2013 Apr;20(2):109-13. doi: 10.3109/09286586.2013.766757.

PMID:
23510315
26.

Seven new loci associated with age-related macular degeneration.

Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, Zack DJ, Arakawa S, Cipriani V, Ripke S, Igo RP Jr, Buitendijk GH, Sim X, Weeks DE, Guymer RH, Merriam JE, Francis PJ, Hannum G, Agarwal A, Armbrecht AM, Audo I, Aung T, Barile GR, Benchaboune M, Bird AC, Bishop PN, Branham KE, Brooks M, Brucker AJ, Cade WH, Cain MS, Campochiaro PA, Chan CC, Cheng CY, Chew EY, Chin KA, Chowers I, Clayton DG, Cojocaru R, Conley YP, Cornes BK, Daly MJ, Dhillon B, Edwards AO, Evangelou E, Fagerness J, Ferreyra HA, Friedman JS, Geirsdottir A, George RJ, Gieger C, Gupta N, Hagstrom SA, Harding SP, Haritoglou C, Heckenlively JR, Holz FG, Hughes G, Ioannidis JP, Ishibashi T, Joseph P, Jun G, Kamatani Y, Katsanis N, N Keilhauer C, Khan JC, Kim IK, Kiyohara Y, Klein BE, Klein R, Kovach JL, Kozak I, Lee CJ, Lee KE, Lichtner P, Lotery AJ, Meitinger T, Mitchell P, Mohand-Saïd S, Moore AT, Morgan DJ, Morrison MA, Myers CE, Naj AC, Nakamura Y, Okada Y, Orlin A, Ortube MC, Othman MI, Pappas C, Park KH, Pauer GJ, Peachey NS, Poch O, Priya RR, Reynolds R, Richardson AJ, Ripp R, Rudolph G, Ryu E, Sahel JA, Schaumberg DA, Scholl HP, Schwartz SG, Scott WK, Shahid H, Sigurdsson H, Silvestri G, Sivakumaran TA, Smith RT, Sobrin L, Souied EH, Stambolian DE, Stefansson H, Sturgill-Short GM, Takahashi A, Tosakulwong N, Truitt BJ, Tsironi EE, Uitterlinden AG, van Duijn CM, Vijaya L, Vingerling JR, Vithana EN, Webster AR, Wichmann HE, Winkler TW, Wong TY, Wright AF, Zelenika D, Zhang M, Zhao L, Zhang K, Klein ML, Hageman GS, Lathrop GM, Stefansson K, Allikmets R, Baird PN, Gorin MB, Wang JJ, Klaver CC, Seddon JM, Pericak-Vance MA, Iyengar SK, Yates JR, Swaroop A, Weber BH, Kubo M, Deangelis MM, Léveillard T, Thorsteinsdottir U, Haines JL, Farrer LA, Heid IM, Abecasis GR; AMD Gene Consortium.

Nat Genet. 2013 Apr;45(4):433-9, 439e1-2. doi: 10.1038/ng.2578. Epub 2013 Mar 3.

27.

Macular telangiectasia type 2.

Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren TF, Peto T, Holz FG, Scholl HP.

Prog Retin Eye Res. 2013 May;34:49-77. doi: 10.1016/j.preteyeres.2012.11.002. Epub 2012 Dec 3. Review.

28.

The IS/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia.

Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UE, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC; MacTel Study Group.

Invest Ophthalmol Vis Sci. 2012 Nov 29;53(12):7889-95. doi: 10.1167/iovs.12-10765.

29.

Idiopathic multifocal choroiditis: a comment on present and past nomenclature.

Essex RW, Wong J, Jampol LM, Dowler J, Bird AC.

Retina. 2013 Jan;33(1):1-4. doi: 10.1097/IAE.0b013e3182641860. No abstract available.

PMID:
23026849
30.

Spontaneous macular hole closure without posterior vitreous detachment in a patient previously treated for diabetic maculopathy.

Errera MH, Wickham L, Keane PA, Bird AC, Ezra E.

Acta Ophthalmol. 2013 Mar;91(2):e156-7. doi: 10.1111/j.1755-3768.2012.02543.x. Epub 2012 Sep 13. No abstract available.

31.

Identification of a potential susceptibility locus for macular telangiectasia type 2.

Parmalee NL, Schubert C, Figueroa M, Bird AC, Peto T, Gillies MC, Bernstein PS, Kiryluk K, Terwilliger JD, Allikmets R; MacTel Project.

PLoS One. 2012;7(8):e24268. Epub 2012 Aug 31.

32.

Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis.

Degli Esposti S, Egan C, Bunce C, Moreland JD, Bird AC, Robson AG.

Invest Ophthalmol Vis Sci. 2012 Sep 25;53(10):6568-75.

PMID:
22899764
33.

"En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia.

Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UE, Clemons TE, Gillies MC, Pauleikhoff D, Rubin GS, Chew EY, Bird AC; MacTel Study Group.

Invest Ophthalmol Vis Sci. 2012 Sep 14;53(10):6145-52.

34.

Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus.

Lutful Kabir FM, Agarwal P, Deinnocentes P, Zaman J, Bird AC, Bird RC.

J Cell Biochem. 2013 Jan;114(1):56-66. doi: 10.1002/jcb.24300.

PMID:
22833492
35.

Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3.

Cipriani V, Leung HT, Plagnol V, Bunce C, Khan JC, Shahid H, Moore AT, Harding SP, Bishop PN, Hayward C, Campbell S, Armbrecht AM, Dhillon B, Deary IJ, Campbell H, Dunlop M, Dominiczak AF, Mann SS, Jenkins SA, Webster AR, Bird AC, Lathrop M, Zelenika D, Souied EH, Sahel JA, Léveillard T; French AMD Investigators, Cree AJ, Gibson J, Ennis S, Lotery AJ, Wright AF, Clayton DG, Yates JR.

Hum Mol Genet. 2012 Sep 15;21(18):4138-50. doi: 10.1093/hmg/dds225. Epub 2012 Jun 13.

36.

Identification of anti-retinal antibodies in patients with age-related macular degeneration.

Morohoshi K, Ohbayashi M, Patel N, Chong V, Bird AC, Ono SJ.

Exp Mol Pathol. 2012 Oct;93(2):193-9. doi: 10.1016/j.yexmp.2012.03.007. Epub 2012 Mar 19.

PMID:
22465421
37.

The prevalence of type 2 idiopathic macular telangiectasia in two African populations.

Sallo FB, Leung I, Mathenge W, Kyari F, Kuper H, Gilbert CE, Bird AC, Peto T; MacTel Study Group.

Ophthalmic Epidemiol. 2012 Aug;19(4):185-9. doi: 10.3109/09286586.2011.638744. Epub 2012 Feb 24.

PMID:
22364548
38.

Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype.

Sofat R, Casas JP, Webster AR, Bird AC, Mann SS, Yates JR, Moore AT, Sepp T, Cipriani V, Bunce C, Khan JC, Shahid H, Swaroop A, Abecasis G, Branham KE, Zareparsi S, Bergen AA, Klaver CC, Baas DC, Zhang K, Chen Y, Gibbs D, Weber BH, Keilhauer CN, Fritsche LG, Lotery A, Cree AJ, Griffiths HL, Bhattacharya SS, Chen LL, Jenkins SA, Peto T, Lathrop M, Leveillard T, Gorin MB, Weeks DE, Ortube MC, Ferrell RE, Jakobsdottir J, Conley YP, Rahu M, Seland JH, Soubrane G, Topouzis F, Vioque J, Tomazzoli L, Young I, Whittaker J, Chakravarthy U, de Jong PT, Smeeth L, Fletcher A, Hingorani AD.

Int J Epidemiol. 2012 Feb;41(1):250-62. doi: 10.1093/ije/dyr204. Epub 2012 Jan 13.

39.

Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization.

Morohoshi K, Patel N, Ohbayashi M, Chong V, Grossniklaus HE, Bird AC, Ono SJ.

Exp Mol Pathol. 2012 Feb;92(1):64-73. doi: 10.1016/j.yexmp.2011.09.017. Epub 2011 Oct 6.

PMID:
22001380
40.

Retinal crystals in type 2 idiopathic macular telangiectasia.

Sallo FB, Leung I, Chung M, Wolf-Schnurrbusch UE, Dubra A, Williams DR, Clemons T, Pauleikhoff D, Bird AC, Peto T; MacTel Study Group.

Ophthalmology. 2011 Dec;118(12):2461-7. doi: 10.1016/j.ophtha.2011.05.022. Epub 2011 Aug 12.

41.

Electroretinogram measures in a septuagenarian population.

Neveu MM, Dangour A, Allen E, Robson AG, Bird AC, Uauy R, Holder GE.

Doc Ophthalmol. 2011 Oct;123(2):75-81. doi: 10.1007/s10633-011-9282-1. Epub 2011 Aug 4.

PMID:
21814827
42.

Serial imaging and structure-function correlates of high-density rings of fundus autofluorescence in retinitis pigmentosa.

Robson AG, Tufail A, Fitzke F, Bird AC, Moore AT, Holder GE, Webster AR.

Retina. 2011 Sep;31(8):1670-9. doi: 10.1097/IAE.0b013e318206d155.

PMID:
21394059
43.

Analysis of candidate genes for macular telangiectasia type 2.

Parmalee NL, Schubert C, Merriam JE, Allikmets K, Bird AC, Gillies MC, Peto T, Figueroa M, Friedlander M, Fruttiger M, Greenwood J, Moss SE, Smith LE, Toomes C, Inglehearn CF, Allikmets R.

Mol Vis. 2010 Dec 14;16:2718-26.

44.

[Unilateral blurred vision associated with combined macular and papillary edema: a 34-year-old male patient].

Krohne TU, Bird AC, Friedlander M.

Ophthalmologe. 2010 Dec;107(12):1160-3. doi: 10.1007/s00347-010-2279-4. German.

PMID:
21052679
45.

Novel mutation in PANK2 associated with retinal telangiectasis.

Sohn EH, Michaelides M, Bird AC, Roberts CJ, Moore AT, Smyth D, Brady AF, Hungerford JL.

Br J Ophthalmol. 2011 Jan;95(1):149-50. doi: 10.1136/bjo.2010.183616. Epub 2010 Oct 24. No abstract available.

PMID:
20974629
46.

Therapeutic targets in age-related macular disease.

Bird AC.

J Clin Invest. 2010 Sep;120(9):3033-41. doi: 10.1172/JCI42437. Epub 2010 Sep 1. Review.

47.

The symmetry of phenotype between eyes of patients with early and late bilateral age-related macular degeneration (AMD).

Mann SS, Rutishauser-Arnold Y, Peto T, Jenkins SA, Leung I, Xing W, Bird AC, Bunce C, Webster AR.

Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):209-14. doi: 10.1007/s00417-010-1483-x. Epub 2010 Aug 25.

PMID:
20737163
48.

Punctate inner choroidopathy: clinical features and outcomes.

Essex RW, Wong J, Fraser-Bell S, Sandbach J, Tufail A, Bird AC, Dowler J.

Arch Ophthalmol. 2010 Aug;128(8):982-7. doi: 10.1001/archophthalmol.2010.157.

PMID:
20696997
49.

Fundus autofluorescence and optical coherence tomography of congenital grouped albinotic spots.

Kim DY, Hwang JC, Moore AT, Bird AC, Tsang SH.

Retina. 2010 Sep;30(8):1217-22. doi: 10.1097/IAE.0b013e3181cea5a5.

50.

Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel Project Report No. 2.

Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Figueroa MJ, Harrington MW; MacTel Research Group.

Ophthalmic Epidemiol. 2010 Jan-Feb;17(1):66-73. doi: 10.3109/09286580903450361.

PMID:
20100102

Supplemental Content

Support Center